Personalized Medicine

Personalized Medicine is a specialist peer-reviewed medical journal devoted to the scientific and clinical development of personalized medicine. The journal was established in 2004 and is published by Future Medicine. Its subject area covers approaches that seek to tailor disease prevention, diagnosis, treatment, and healthcare decision-making to individual biological and clinical characteristics. This broad field can include genomics, molecular diagnostics, biomarker research, pharmacogenomics, targeted therapies, clinical stratification, and the implementation of individualized care pathways. The publication appears as a bimonthly journal, giving it a regular schedule for disseminating research and professional analysis in a field that connects laboratory science, clinical medicine, pharmaceutical development, and health policy. As a journal brand rather than a consumer healthcare brand, its principal offering is scholarly content: research articles, reviews, and other forms of professional medical publishing. Its audience includes researchers, physicians, pharmacists, biotechnology and pharmaceutical professionals, diagnostic specialists, and policymakers interested in the translation of personalized medicine into clinical practice. Personalized Medicine is indexed by several major scientific and medical information services, including Chemical Abstracts, Current Contents/Clinical Medicine, Embase/Excerpta Medica, Science Citation Index Expanded, and Scopus. These indexing relationships increase the discoverability of the journal's articles within academic and biomedical research systems. The journal's inclusion in the Science Citation Index Expanded and Scopus also places it within widely used infrastructure for literature retrieval and citation analysis. The journal's identity is closely tied to the development of personalized medicine as an interdisciplinary field. Rather than representing a single therapy, diagnostic platform, or healthcare provider, it functions as an editorial and scholarly platform for discussing how individualized biological information can influence medical decisions. Available reference material confirms its establishment, publishing cadence, publisher, subject focus, and indexing coverage, but does not provide reliable information about its editors, ownership structure, headquarters, circulation, subscription revenue, or current impact metrics. Those details are therefore left unspecified.

Personalized Medicine was established in 2004 as a peer-reviewed medical journal addressing the emerging field of personalized medicine. Its creation coincided with increasing interest in using genetic, molecular, and clinical information to distinguish patient groups and improve the selection of preventive or therapeutic interventions. The journal provides a dedicated publishing venue for this interdisciplinary area, which spans biomedical discovery, clinical research, diagnostics, drug development, and healthcare delivery. The journal is published by Future Medicine and appears bimonthly. Its publishing model is that of a specialist scientific periodical: it supports the communication and evaluation of research and professional commentary rather than selling medicines, diagnostic devices, or direct-to-consumer healthcare services. The publication's subject scope is consequently broader than any one technology. It may encompass the scientific basis of individualized treatment, clinical implementation, biomarker assessment, pharmacogenomic decision-making, and the practical or policy challenges involved in adapting healthcare to patient-level variation. Over time, the journal's visibility has been supported by inclusion in established bibliographic and citation databases. Reference material identifies indexing in Chemical Abstracts, Current Contents/Clinical Medicine, Embase/Excerpta Medica, Science Citation Index Expanded, and Scopus. These services are used by researchers and healthcare professionals to locate biomedical literature and assess scholarly dissemination. Indexing in multiple systems is therefore an important part of the journal's professional positioning and reach. A 2016 Journal Citation Reports entry listed an impact factor of 1.010 and placed the journal 223rd among 256 journals in the Pharmacology & Pharmacy category. That figure is historical and should not be treated as a current performance measure. The available material does not establish the journal's current editorial leadership, ownership beyond its stated publisher, publication volume, current metrics, or current operating status in detail. No verified campaigns, scandals, corporate transactions, or leadership changes are identified in the supplied references.

• 2016

  Historical Journal Citation Reports metric

  [1]Personalized Medicine (journal)en.wikipedia.org

  The journal was reported with a 2016 impact factor of 1.010 and ranked 223rd of 256 journals in Pharmacology & Pharmacy.

• 2004

  Journal established

  [1]Personalized Medicine (journal)en.wikipedia.org

  Personalized Medicine was established as a peer-reviewed medical journal focused on the developing field of personalized medicine.

An international scholarly journal positioned at the intersection of personalized medicine, clinical practice, biomedical research, diagnostics, pharmaceuticals, and healthcare policy.

• Peer-reviewed medical journal · 2004

  Personalized Medicine

  A bimonthly peer-reviewed journal covering personalized medicine. Its subject matter is relevant to biomedical researchers, clinicians, diagnostic professionals, pharmaceutical and biotechnology specialists, and healthcare policymakers. The journal serves as a scholarly platform for research and analysis concerning the use of individual biological and clinical information in prevention, diagnosis, treatment, and healthcare decision-making.

1. 1Personalized Medicine (journal)en.wikipedia.org
2. 2Personalized Medicine official journal websitefuturemedicine.com